A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity
Open Access
- 14 November 2007
- journal article
- review article
- Published by Springer Nature in BMC Medicine
- Vol. 5 (1) , 32
Abstract
Meta-analyses of N-acetylcysteine (NAC) for preventing contrast-induced nephrotoxicity (CIN) have led to disparate conclusions. Here we examine and attempt to resolve the heterogeneity evident among these trials.Keywords
This publication has 105 references indexed in Scilit:
- Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trialAmerican Heart Journal, 2007
- Acetylcysteine In Diabetes (AID): A randomized study of acetylcysteine for the prevention of contrast nephropathy in diabeticsAmerican Heart Journal, 2006
- N-Acetylcysteine and contrast-induced nephropathy: A meta-analysis of 13 randomized trialsAmerican Heart Journal, 2006
- N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-upAmerican Heart Journal, 2004
- A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effectAmerican Heart Journal, 2004
- Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiographyAmerican Heart Journal, 2003
- Measuring inconsistency in meta-analysesBMJ, 2003
- Model-Based Clustering, Discriminant Analysis, and Density EstimationJournal of the American Statistical Association, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996